We evaluated 113 female partners of men with erectile dysfunction (ED) attending a sexual dysfunction clinic in order to define sexual dysfunction among these women. In all, 51 (45%) women denied having any sexual dysfunction. The other 62 (55%) responded to questions classifying their complaint(s) according to the international classification of female sexual dysfunction (FSD) in the following topics (40/62, 65%, reported having more than one problem): decreased sexual desire (n ¼ 35, 56%), sexual aversion (none), arousal (n ¼ 23, 37%) and orgasmic disorders (n ¼ 39, 63%), dyspareunia (n ¼ 19, 31%), vaginismus (n ¼ 3, 5%), and noncoital sexual pain (none). Many female partners of men with ED report having some form of sexual disorder, mostly orgasmic problems and decreased sexual desire. Therefore, for optimal outcome of ED treatment, evaluation and treatment of male and FSD should be addressed as one unit within the context of the couple, and be incorporated into one clinic of sexual medicine.
Introduction
For most individuals, a satisfying sex life is an important ingredient of a healthy lifestyle. Sexual problems are widespread and related to both health status and psychosocial factors and may affect the relationship between the couple. [1] [2] [3] [4] Erectile dysfunction (ED) hampers the quality of life of both the male and his female partner. Effective treatments for ED are available, but re-establishing erectile function does not necessarily re-establish a satisfying sexual relationship of the couple due to an existing female sexual dysfunction (FSD), 3 thus the increasing awareness and interest in FSD. Several surveys have estimated that 18-76% of adult females complain of sexual dysfunction and that many have never been evaluated by their physicians. [2] [3] [4] Therefore, for optimal outcome of ED treatment, the management of sexual problems calls for coordination of the evaluation and treatment of male and female sexual problems as one unit within the context of the couple. 1, 3, [5] [6] [7] We designed this prospective study to characterize sexual dysfunction in women who accompanied their partners to our male sexual dysfunction clinic.
Materials and methods
During the study period, 295 men were evaluated, of whom 205 (69%) were accompanied by their female partners to our Male Sexual Dysfunction Clinic. Of these 205 consecutive couples, 113 women (55.1%, mean age 59.372.06 years, range 27-83) agreed to participate in this prospective study. Their 113 male partners (mean age of 64.673.20 years, range 29-85) were being evaluated at the clinic due to ED. Each female partner was given the choice of filling out the questionnaire either in the presence of her partner or in privacy. They were also given the option of answering the questions themselves or with the help of one of the investigators.
The Brief Index of Sexual Functioning for Women (BISF-W) 8 was used to determine the female participants' complaints according to the classification of FSD: 9 The questions addressed the following topics:
1. Female hypoactive sexual desire disorder (FHSD) defined as 'The persistent or recurrent deficiency (or absence) of sexual fantasies, and/or desire for, or receptivity to, sexual activity, which causes personal distress.' 2. Sexual aversion disorder (SAD) defined as 'The persistent or recurrent phobic aversion to and avoidance of sexual contact with a sexual partner which causes personal distress.' 3. Female sexual arousal disorder (FSAD) defined as 'The persistent or recurrent inability to attain or maintain sufficient sexual excitement, causing personal distress. It may be expressed as a lack of subjective excitement or a lack of genital lubrication/swelling or other somatic response.' 4. Orgasmic disorder defined as 'The persistent or recurrent difficulty, delay in, or absence of attaining orgasm following sufficient sexual stimulation and arousal, which causes personal distress.' 5. Dyspareunia defined as 'The persistent or recurrent genital pain associated with sexual intercourse which causes personal distress.' 6. Vaginismus defined as 'The persistent or recurrent involuntary spasm of the musculature of the outer third of the vagina that interferes with vaginal penetration, which causes personal distress.' 7. Noncoital sexual pain disorder defined as 'The persistent or recurrent genital pain induced by noncoital sexual stimulation which causes personal distress.'
The BISF-W questionnaire does not contain any questions that refer to the possibility of noncoital sexual pain disorder; therefore, all participants were asked directly if noncoital sexual stimulation (hugging, kissing, fantasizing) caused them genital pain. Based upon their replies, the women were classified to at least one of the FSD categories. Any positive response was considered as an FSD.
Results
Of the 113 women in the study, 51 (45%) denied having any sexual disorders. The remaining 62 (55%) reported having at least one type of sexual dysfunction and 40 them (64%) reported having more than one. The mean duration of their sexual problem(s) was 3.5 years (range 8 months to 10 years). In all, 39 (63%) reported having orgasmic problems, 35 (56%) decreased sexual desire, 23 (37%) arousal disorder, 19 (31%) dyspareunia, and 3 (5%) vaginismus. None of the women complained of SAD or noncoital sexual pain disorder. The distribution of the type of sexual dysfunction in the patient cohort is shown in Figure 1 .
The visit to the male sexual dysfunction clinic had been initiated by 103 (91%) of these women, and 72 (64%) women expected to be questioned about their own personal sexual dysfunction.
The etiology of the ED in most of the patients (n ¼ 98, 87%) was mixed psychogenic and organic. The men underwent a medical and sexual history, physical examination, psychological profile and endocrine evaluation for the etiology of ED. Invasive evaluations, such as Doppler ultrasound examination of penile vasculature with artificial erection induced by intrapenile injection of vasoactive medications, cavernosography, and cavernosometery, were reserved for selected patients. There was no correlation between an existing FSD and the etiology or timing of the ED.
Discussion
Male sexual function has long been a part of urological practice and research. Optimal management of ED requires the partner's collaboration. Partners' resentment of 'artificial' means of erection may cause discontinuation of effective treatments for ED. 7 In spite of the impact of ED on the sexual life of female partners, much relevant information on FSD is still lacking or is insufficient. A broad-based international effort improved the diagnosis of FSD by means of standardization of categories of disturbances and/or type of complaint(s). 5, 6, 9 Although there are some concerns regarding the reliability of the suggested classifications, 10, 11 the Report of The International Consensus Development Conference on Female Sexual Dysfunction recommended the BISF-W in the assessment of FSD, 9 and we consider that the questionnaires had been effectively applied in the current study in terms of nature and quantity of data yield. While using this questionnaire for assessment and classification of the women's sexual dysfunction, however, we did have some difficulty in convincing all of the eligible women to take the time to use this time-consuming tool. 
Sexual dysfunction in female partners of men with ED A Greenstein et al
It is noteworthy that the majority (91%) of our study women initiated their partner's visit to the clinic and that 64% of them had anticipated being questioned about their personal sexual problems. Indeed, the relatively high rate of FSDs reported in this study may have accounted for the initiation of the visit of their partners to our Male Sexual Dysfunction Clinic.
The high proportion of female partners with FSD in our study (55%) demonstrated the importance of taking a sexual dysfunction history from both partners. FSD, which appeared to have a strong negative effect on the success of the male partner's treatment, is a factor that needs to be recognized by urologists who treat male sexual dysfunction. 12 In our current experience, the 'couple' approach helped to detect heretofore unidentified FSD in apparently healthy women.
As we evaluated females accompanying their partners, our results may not reflect the characteristics of females specifically seeking evaluation for their FSD. In all, 55% of the women accompanying their partners comprised our study population: if all the women accompanying their partners had agreed to participate, this could have affected our results. Moreover, since we did not expect such a high percentage of female partners with sexual problems of their own, we did not consider collecting data that could indicate whether there was any correlation between the timing of the FSD appearance with the timing of their partners' ED. The design of this study was to look upon these women solely as partners of the men being treated in our Male Sexual Dysfunction Clinic. We limited our focus to whether or not they felt that they, themselves, had any problems in functioning sexually and the nature of their problems. We did not expand our investigation to include the many other parameters relevant to FSD (age, hormonal status, religious status, education, previous sexual experience, parents' attitude toward sexual activity at various stage of life, etc.). Furthermore, due to some women's refusal to address the questions and to participate in our study, information about their FSD and correlation to the various parameters affecting sexual function is unavailable.
Relational factors in addition to organic, psychological, can coexist in men with ED, and FSD may play a role on inter-relationship of the couple. Therefore, using structured interviews such as the SIEDY that provides a quantitation of disturbances in relationship with a partner could be relevant in everyday clinical practice as a guide for subsequent psychosexual counseling for the couple. 13 In conclusion, we found that a high proportion of female partners of men with ED (55%) report having one or more FSD. Most of the visits to the male sexual dysfunction clinic (91%) were initiated by the female partners, and most of the studied females (64%) had expected to be questioned about their personal FSD. Therefore, for optimal outcome of ED treatment, evaluation and treatment of male and FSD should be addressed as one unit within the context of the couple, and be incorporated into one clinic of sexual medicine.
